Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum days for report: 14 days

What are the prerequisites for the test KIT Gene Analysis Test by NGS (Hotspot Regions)

  • Sample type: Tissue (formalin-fixed paraffin-embedded)
  • Minimum Tumor Content: 20%
  • Specimen Stability: Room temperature
  • Specimen Storage: Room temperature
  • Shipping Conditions: Room temperature

What are the measure values for the test KIT Gene Analysis Test by NGS (Hotspot Regions)

Gene Region Measure Value
KIT Hotspot Regions Varies depending on the specific mutation detected

What does this test KIT Gene Analysis Test by NGS (Hotspot Regions) identify?

  • Test Name: KIT Gene Analysis Test by NGS (Hotspot Regions)
  • Identifies: This test uses Next Generation Sequencing (NGS) technology to analyze the hotspot regions of the KIT gene. The KIT gene encodes a protein called KIT receptor tyrosine kinase, which plays a crucial role in cell growth and division. Mutations in the hotspot regions of the KIT gene have been associated with various cancers, including gastrointestinal stromal tumors (GIST), mast cell tumors, and acute myeloid leukemia.
  • Purpose: The test is used to identify specific mutations in the hotspot regions of the KIT gene that may be driving the development and progression of cancer. This information can help guide treatment decisions, such as the use of targeted therapies that specifically target the mutated KIT protein.

Why is this test KIT Gene Analysis Test by NGS (Hotspot Regions) taken?

Why is the KIT Gene Analysis Test by NGS (Hotspot Regions) taken?

The KIT Gene Analysis Test by NGS (Hotspot Regions) is taken to identify mutations in the KIT gene that are known to be associated with certain types of cancer, such as gastrointestinal stromal tumors (GISTs) and acute myeloid leukemia (AML).

By analyzing the hotspot regions of the KIT gene using Next-Generation Sequencing (NGS) technology, healthcare providers can determine if a patient's cancer is driven by specific mutations in this gene. This information is crucial for guiding treatment decisions, as some targeted therapies are available that specifically target KIT mutations.

Overall, the KIT Gene Analysis Test by NGS (Hotspot Regions) helps healthcare providers personalize cancer treatment by identifying genetic mutations that may influence the effectiveness of certain therapies.

No FAQs available.

Customer Google Rating